{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:14:53Z","timestamp":1789049693417,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Conventional HIV-1 management relies on clinical phenotypes, assuming a uniform inflammatory status and overlooking biological heterogeneity. We aimed to employ a high-throughput proteomic approach to stratify people living with HIV (PLWH) based on plasma inflammatory profiles and evaluate their association with comorbidity burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study included 30 PLWH (10 treatment-na\u00efve, 10 ART-suppressed, and 10 elite controllers (EC)) and 10 seronegative controls. Unsupervised hierarchical clustering was applied to 87 inflammatory proteins (analyzed by proximity extension assay and ELISA). A Random Forest model stabilized with 1,000 trees identified the variables defining the biotypes. Comorbidity burden was assessed within the virally suppressed groups (ART-suppressed and EC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clustering revealed two distinct biological profiles independent of clinical classifications: a high-inflammation biotype (n=11) and a low-inflammation biotype (n=19). Within the treatment-na\u00efve, elite controller, and ART-suppressed groups, 60%, 30%, and 20% of participants, respectively, were classified as belonging to the high-inflammation biotype. PDL1, CD40, TNF, LAP-TGFbeta1, and SLAMF1 were the top biological drivers of this separation. A trend for a higher comorbidity burden was observed in the high-inflammation biotype compared to the low-inflammation group (p=0.06).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Plasma inflammatory profiling stratifies PLWH into distinct biological biotypes that bypass conventional classifications. The observed differences in comorbidity burden between inflammatory biotypes warrant further investigation in larger prospective studies to clarify their clinical relevance and potential implications for long-term health outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1947773","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:46:57Z","timestamp":1789048017000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Unsupervised proteomic stratification of people living with HIV reveals inflammatory biotypes beyond conventional clinical classifications"],"prefix":"10.3389","volume":"17","author":[{"given":"Norma","family":"Rall\u00f3n","sequence":"first","affiliation":[{"name":"HIV and Viral Hepatitis Research Laboratory, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM)","place":["Madrid, Spain"]},{"name":"Hospital Universitario Rey Juan Carlos","place":["M\u00f3stoles, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Restrepo","sequence":"additional","affiliation":[{"name":"Hospital Universitario Rey Juan Carlos","place":["M\u00f3stoles, Spain"]},{"name":"HIV and Viral Hepatitis Research Laboratory, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Manquillo","sequence":"additional","affiliation":[{"name":"HIV and Viral Hepatitis Research Laboratory, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM)","place":["Madrid, Spain"]},{"name":"Hospital Universitario Rey Juan Carlos","place":["M\u00f3stoles, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"P\u00e9rez-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Cobiomic Bioscience","place":["C\u00f3rdoba, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Mahillo","sequence":"additional","affiliation":[{"name":"Department of Statistics, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nistal","sequence":"additional","affiliation":[{"name":"Hospital Universitario Rey Juan Carlos","place":["M\u00f3stoles, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aws","family":"Al-Hayani","sequence":"additional","affiliation":[{"name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Cabello","sequence":"additional","affiliation":[{"name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Carrillo","sequence":"additional","affiliation":[{"name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Prieto","sequence":"additional","affiliation":[{"name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"G\u00f3rgolas","sequence":"additional","affiliation":[{"name":"Hospital Universitario Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Hospital General Universitario Gregorio Mara\u00f1\u00f3n","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednico Universitario San Carlos","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Estrada","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednico Universitario San Carlos","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Benito","sequence":"additional","affiliation":[{"name":"HIV and Viral Hepatitis Research Laboratory, Instituto de Investigaci\u00f3n Sanitaria Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Universidad Aut\u00f3noma de Madrid (IIS-FJD, UAM)","place":["Madrid, Spain"]},{"name":"Hospital Universitario Rey Juan Carlos","place":["M\u00f3stoles, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PloS Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw275","article-title":"Immunologic biomarkers, morbidity, and mortality in treated HIV infection","volume":"214","author":"Hunt","year":"2016","journal-title":"J Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis406","article-title":"HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation","volume":"55","author":"Armah","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/QCO.0000000000000510","article-title":"Assessing inflammation and its role in comorbidities among persons living with HIV","volume":"32","author":"Peterson","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e328345a328","article-title":"Elite controllers as a model of functional cure","volume":"6","author":"Autran","year":"2011","journal-title":"Curr Opin HIV AIDS"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1086\/524143","article-title":"Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy","volume":"197","author":"Hunt","year":"2008","journal-title":"J Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835a9950","article-title":"Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers","volume":"26","author":"Pereyra","year":"2012","journal-title":"AIDS"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofu117","article-title":"Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics","volume":"2","author":"Li","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit581","article-title":"Evidence for innate immune system activation in HIV type 1\u2013infected elite controllers","volume":"209","author":"Krishnan","year":"2014","journal-title":"J Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1038\/s41598-022-10330-9","article-title":"Increased biomarkers of cardiovascular risk in HIV-1 viremic controllers and low persistent inflammation in elite controllers and ART-suppressed individuals","volume":"12","author":"Caetano","year":"2022","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofx064","article-title":"A subset of extreme human immunodeficiency virus (HIV) controllers is characterized by a small HIV blood reservoir and a weak T-cell activation level","volume":"4","author":"Canou\u00ef","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102111","article-title":"Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status","volume":"24","author":"Sperk","year":"2021","journal-title":"iScience"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00118-15","article-title":"Increased levels of macrophage inflammatory proteins result in resistance to R5-tropic HIV-1 in a subset of elite controllers","volume":"89","author":"Walker","year":"2015","journal-title":"J Virol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02051-16","article-title":"Cytokines elevated in HIV elite controllers reduce HIV replication in vitro and modulate HIV restriction factor expression","volume":"91","author":"Jacobs","year":"2017","journal-title":"J Virol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003691","article-title":"Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers","volume":"9","author":"Hatano","year":"2013","journal-title":"PloS Pathog"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70901","article-title":"Distinctive inflammatory proteomic profile of HIV\u20101 elite controllers: A comparative study in a Spanish cohort","volume":"98","author":"Rall\u00f3n","year":"2026","journal-title":"J Med Virol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105089","article-title":"Targeted plasma proteomics reveals upregulation of distinct inflammatory pathways in people living with HIV","volume":"25","author":"Vadaq","year":"2022","journal-title":"iScience"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283489d1f","article-title":"The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of US women","volume":"25","author":"Keating","year":"2011","journal-title":"AIDS"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000545","article-title":"The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation","volume":"29","author":"Wada","year":"2015","journal-title":"AIDS"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/v9040064","article-title":"Targeting TNF and TNF receptor pathway in HIV-1 infection: from immune activation to viral reservoirs","volume":"9","author":"Pasquereau","year":"2017","journal-title":"Viruses"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.68.3.373","article-title":"The emerging role of CD40 ligand in HIV infection","volume":"68","author":"Kornbluth","year":"2000","journal-title":"J Leukoc Biol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12823","article-title":"T-cell exhaustion in HIV infection","volume":"292","author":"Fenwick","year":"2019","journal-title":"Immunol Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2025.09.006","article-title":"Galectin-9 promotes colon cancer development by polarizing macrophages toward the M2 phenotype","author":"Zhang","year":"2025","journal-title":"Cancer Genet"},{"key":"B26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032713-120257","article-title":"TGF-\u03b2 activation and function in immunity","volume":"32","author":"Travis","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-immunol-030409-101302","article-title":"SLAM family receptors and SAP adaptors in immunity","volume":"29","author":"Cannons","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1086\/314572","article-title":"Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure","volume":"179","author":"Aukrust","year":"1999","journal-title":"J Infect Dis"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13070540","article-title":"Persistently elevated expression of systemic, soluble co-inhibitory immune checkpoint molecules in people living with HIV before and one year after antiretroviral therapy","volume":"13","author":"Labuschagne Naidoo","year":"2024","journal-title":"Pathogens"},{"key":"B30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11904-020-00509-y","article-title":"Immunomodulatory and anti-inflammatory strategies to reduce comorbidity risk in people with HIV","volume":"17","author":"Kettelhut","year":"2020","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.53388\/2026926005","article-title":"Liquid biopsy \u2013 driven cancer genetics in the ultrasensitive and hyper-data-integration eras","volume":"9","author":"Liu","year":"2026","journal-title":"Cancer Adv"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergen.2025.07.014","article-title":"Pan-cancer methylation analysis of circulating cell-free DNA","author":"Dong","year":"2025","journal-title":"Cancer Genet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.cancergen.2025.03.004","article-title":"Identification of new immune target and signaling for cancer immunotherapy","author":"Narote","year":"2025","journal-title":"Cancer Genet"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-018-0411-2","article-title":"Inflammation and metabolic complications in HIV","volume":"15","author":"Bourgi","year":"2018","journal-title":"Curr HIV\/AIDS Rep"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000755","article-title":"HIV and cardiovascular disease: the role of inflammation","volume":"17","author":"Dirajlal-Fargo","year":"2022","journal-title":"Curr Opin HIV AIDS"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.70017","article-title":"Biomarkers of inflammation and coagulation predict non-AIDS-defining events in a prospective cohort of virologically suppressed people living with HIV","volume":"26","author":"Saumoy","year":"2025","journal-title":"HIV Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21945","article-title":"Association between peripheral adipokines and inflammation markers: A systematic review and meta-analysis","volume":"25","author":"Gra\u00dfmann","year":"2017","journal-title":"Obesity"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2025.106669","article-title":"Association between interleukin-6, C-reactive protein and chronic kidney disease outcomes: A systematic review and meta-analysis","volume":"145","author":"Abdel-Rahman","year":"2026","journal-title":"Eur J Intern Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30264-4","article-title":"HIV controllers: to treat or not to treat? Is that the right question","volume":"6","author":"Noel","year":"2019","journal-title":"Lancet HIV"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1947773\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:46:58Z","timestamp":1789048018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1947773\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":39,"alternative-id":["10.3389\/fimmu.2026.1947773"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1947773","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1947773"}}